| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tumor Suppressor Protein p53 | 163 | 2024 | 3670 | 14.910 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 74 | 2022 | 529 | 8.690 |
Why?
|
| Proto-Oncogene Proteins | 58 | 2021 | 2624 | 6.010 |
Why?
|
| Genes, p53 | 47 | 2023 | 1146 | 5.060 |
Why?
|
| Nuclear Proteins | 54 | 2022 | 3472 | 3.950 |
Why?
|
| Ubiquitin-Protein Ligases | 27 | 2022 | 882 | 3.240 |
Why?
|
| Mice | 172 | 2024 | 36041 | 2.690 |
Why?
|
| Li-Fraumeni Syndrome | 15 | 2023 | 167 | 2.560 |
Why?
|
| Carcinogenesis | 12 | 2024 | 1037 | 2.240 |
Why?
|
| Animals | 198 | 2024 | 62807 | 2.200 |
Why?
|
| Neoplasms, Experimental | 11 | 2018 | 790 | 2.120 |
Why?
|
| Osteosarcoma | 8 | 2023 | 948 | 2.050 |
Why?
|
| Apoptosis | 49 | 2022 | 7837 | 1.950 |
Why?
|
| Mutation | 59 | 2024 | 15924 | 1.910 |
Why?
|
| Mutation, Missense | 16 | 2024 | 1197 | 1.720 |
Why?
|
| Gene Expression Regulation, Neoplastic | 32 | 2024 | 9099 | 1.640 |
Why?
|
| Cell Transformation, Neoplastic | 22 | 2024 | 2472 | 1.520 |
Why?
|
| Disease Models, Animal | 28 | 2024 | 7471 | 1.410 |
Why?
|
| Transcriptional Activation | 18 | 2023 | 1146 | 1.350 |
Why?
|
| Triple Negative Breast Neoplasms | 5 | 2024 | 1381 | 1.340 |
Why?
|
| Mice, Transgenic | 39 | 2024 | 4371 | 1.320 |
Why?
|
| Mice, Knockout | 35 | 2024 | 5840 | 1.310 |
Why?
|
| Tumor Suppressor Proteins | 14 | 2015 | 1904 | 1.310 |
Why?
|
| Gain of Function Mutation | 2 | 2022 | 134 | 1.300 |
Why?
|
| Neoplasms | 34 | 2019 | 15915 | 1.250 |
Why?
|
| Neuroendocrine Tumors | 4 | 2022 | 653 | 1.100 |
Why?
|
| Pancreatic Neoplasms | 8 | 2024 | 5248 | 1.050 |
Why?
|
| Fibroblasts | 13 | 2022 | 1670 | 1.050 |
Why?
|
| Bone Neoplasms | 8 | 2023 | 2668 | 1.040 |
Why?
|
| Mice, Inbred C57BL | 42 | 2024 | 7232 | 1.030 |
Why?
|
| Transcription Factors | 20 | 2023 | 5505 | 1.010 |
Why?
|
| Gene Expression Regulation | 24 | 2020 | 4199 | 1.010 |
Why?
|
| Mammary Neoplasms, Animal | 3 | 2024 | 238 | 1.000 |
Why?
|
| Organ Specificity | 5 | 2023 | 754 | 0.980 |
Why?
|
| Transcriptome | 3 | 2024 | 1948 | 0.980 |
Why?
|
| Mammary Neoplasms, Experimental | 4 | 2024 | 557 | 0.980 |
Why?
|
| Cell Cycle | 21 | 2015 | 2150 | 0.970 |
Why?
|
| DNA-Binding Proteins | 18 | 2020 | 5066 | 0.930 |
Why?
|
| DNA Damage | 19 | 2017 | 1989 | 0.900 |
Why?
|
| Cell Cycle Proteins | 17 | 2021 | 2129 | 0.900 |
Why?
|
| Ribonuclease III | 3 | 2019 | 188 | 0.890 |
Why?
|
| DEAD-box RNA Helicases | 3 | 2019 | 263 | 0.850 |
Why?
|
| Signal Transduction | 27 | 2024 | 12222 | 0.820 |
Why?
|
| Embryonic Development | 5 | 2023 | 315 | 0.770 |
Why?
|
| Endogenous Retroviruses | 2 | 2020 | 43 | 0.760 |
Why?
|
| Carrier Proteins | 5 | 2021 | 2139 | 0.750 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 3 | 2024 | 1409 | 0.710 |
Why?
|
| Pancreas, Exocrine | 1 | 2020 | 23 | 0.700 |
Why?
|
| Ultraviolet Rays | 13 | 2017 | 591 | 0.700 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 2 | 2023 | 441 | 0.700 |
Why?
|
| Sarcoma, Experimental | 3 | 2009 | 68 | 0.700 |
Why?
|
| Cell Line, Tumor | 28 | 2024 | 14875 | 0.680 |
Why?
|
| Liver Neoplasms | 6 | 2023 | 4809 | 0.680 |
Why?
|
| Radiation, Ionizing | 3 | 2019 | 192 | 0.680 |
Why?
|
| Embryo, Mammalian | 14 | 2018 | 758 | 0.670 |
Why?
|
| Aging | 7 | 2018 | 1578 | 0.670 |
Why?
|
| Genetic Predisposition to Disease | 15 | 2021 | 5750 | 0.660 |
Why?
|
| Phenotype | 21 | 2017 | 6515 | 0.660 |
Why?
|
| Lymphoma | 5 | 2017 | 1514 | 0.660 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 5 | 2024 | 1295 | 0.650 |
Why?
|
| Humans | 143 | 2024 | 271884 | 0.650 |
Why?
|
| Cell Biology | 1 | 2018 | 17 | 0.640 |
Why?
|
| Proteasome Endopeptidase Complex | 3 | 2014 | 599 | 0.640 |
Why?
|
| Base Pair Mismatch | 1 | 2018 | 82 | 0.640 |
Why?
|
| Carcinoma in Situ | 1 | 2022 | 496 | 0.630 |
Why?
|
| Alleles | 15 | 2023 | 2599 | 0.630 |
Why?
|
| E2F6 Transcription Factor | 1 | 2017 | 10 | 0.600 |
Why?
|
| Proto-Oncogene Protein c-ets-2 | 1 | 2017 | 21 | 0.600 |
Why?
|
| Genes, Lethal | 7 | 2006 | 132 | 0.590 |
Why?
|
| RNA, Small Nucleolar | 1 | 2017 | 26 | 0.590 |
Why?
|
| Retinoids | 1 | 2018 | 151 | 0.580 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2022 | 695 | 0.580 |
Why?
|
| Single-Cell Analysis | 2 | 2021 | 546 | 0.580 |
Why?
|
| Pancreatitis | 1 | 2020 | 293 | 0.580 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 11 | 2013 | 541 | 0.550 |
Why?
|
| Gastrointestinal Tract | 1 | 2019 | 326 | 0.550 |
Why?
|
| Tamoxifen | 2 | 2018 | 906 | 0.540 |
Why?
|
| Germ-Line Mutation | 10 | 2021 | 1102 | 0.540 |
Why?
|
| Gene Editing | 1 | 2018 | 231 | 0.530 |
Why?
|
| Transcription, Genetic | 19 | 2014 | 3417 | 0.530 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2022 | 1720 | 0.530 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2022 | 1237 | 0.500 |
Why?
|
| Hematopoietic Stem Cells | 4 | 2013 | 1373 | 0.500 |
Why?
|
| Ubiquitin | 4 | 2014 | 335 | 0.500 |
Why?
|
| CRISPR-Cas Systems | 1 | 2018 | 353 | 0.500 |
Why?
|
| Genetic Heterogeneity | 3 | 2018 | 327 | 0.490 |
Why?
|
| Promoter Regions, Genetic | 21 | 2014 | 3262 | 0.490 |
Why?
|
| Carcinoma, Pancreatic Ductal | 3 | 2021 | 1825 | 0.490 |
Why?
|
| Homeostasis | 1 | 2020 | 959 | 0.480 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2008 | 815 | 0.480 |
Why?
|
| Oxygen Consumption | 2 | 2014 | 423 | 0.480 |
Why?
|
| Phospholipases A2, Calcium-Independent | 1 | 2014 | 20 | 0.480 |
Why?
|
| Ubiquitination | 6 | 2015 | 577 | 0.480 |
Why?
|
| Gastrointestinal Diseases | 1 | 2019 | 617 | 0.470 |
Why?
|
| Protein Binding | 14 | 2022 | 3528 | 0.470 |
Why?
|
| Chromosomal Instability | 2 | 2006 | 230 | 0.470 |
Why?
|
| RNA, Messenger | 16 | 2010 | 6489 | 0.450 |
Why?
|
| Mice, Mutant Strains | 7 | 2014 | 664 | 0.450 |
Why?
|
| Neoplasm Metastasis | 8 | 2021 | 5330 | 0.450 |
Why?
|
| Radiation Injuries | 2 | 2019 | 1472 | 0.440 |
Why?
|
| Ribosomal Proteins | 2 | 2011 | 135 | 0.440 |
Why?
|
| Intestinal Mucosa | 3 | 2009 | 1125 | 0.440 |
Why?
|
| Tumor Protein p73 | 5 | 2015 | 114 | 0.440 |
Why?
|
| Gene Deletion | 8 | 2014 | 1487 | 0.430 |
Why?
|
| Gene Expression | 8 | 2017 | 3689 | 0.430 |
Why?
|
| Base Sequence | 30 | 2008 | 5499 | 0.430 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2023 | 2174 | 0.430 |
Why?
|
| Reactive Oxygen Species | 4 | 2022 | 1011 | 0.430 |
Why?
|
| Co-Repressor Proteins | 4 | 2023 | 120 | 0.430 |
Why?
|
| Genes, ras | 4 | 2014 | 681 | 0.420 |
Why?
|
| Cell Proliferation | 14 | 2024 | 7300 | 0.420 |
Why?
|
| Breast Neoplasms | 10 | 2022 | 16241 | 0.420 |
Why?
|
| Genes | 8 | 2001 | 613 | 0.410 |
Why?
|
| Neoplasm Proteins | 9 | 2006 | 3363 | 0.410 |
Why?
|
| Lymphoma, B-Cell | 3 | 2015 | 936 | 0.410 |
Why?
|
| Female | 65 | 2024 | 149143 | 0.410 |
Why?
|
| Molecular Chaperones | 4 | 2023 | 268 | 0.400 |
Why?
|
| Radiation Tolerance | 5 | 2018 | 636 | 0.400 |
Why?
|
| Carcinoma, Squamous Cell | 6 | 2017 | 5603 | 0.390 |
Why?
|
| Trans-Activators | 8 | 2015 | 1660 | 0.390 |
Why?
|
| Zebrafish Proteins | 1 | 2012 | 158 | 0.390 |
Why?
|
| X-linked Nuclear Protein | 3 | 2022 | 55 | 0.380 |
Why?
|
| Hemangiosarcoma | 1 | 2014 | 237 | 0.380 |
Why?
|
| Histone Chaperones | 2 | 2023 | 32 | 0.380 |
Why?
|
| Heterozygote | 6 | 2016 | 1057 | 0.380 |
Why?
|
| Cyclins | 8 | 2002 | 470 | 0.380 |
Why?
|
| Crosses, Genetic | 7 | 2013 | 257 | 0.360 |
Why?
|
| DNA | 17 | 2023 | 3088 | 0.360 |
Why?
|
| Oncogenes | 5 | 2011 | 701 | 0.360 |
Why?
|
| Cells, Cultured | 18 | 2021 | 5787 | 0.350 |
Why?
|
| Adenocarcinoma | 3 | 2024 | 7975 | 0.350 |
Why?
|
| Inflammation | 1 | 2020 | 2533 | 0.350 |
Why?
|
| Gene Expression Regulation, Developmental | 7 | 2011 | 1524 | 0.350 |
Why?
|
| Cell Death | 3 | 2023 | 689 | 0.340 |
Why?
|
| Up-Regulation | 7 | 2017 | 2457 | 0.340 |
Why?
|
| Limb Buds | 1 | 2009 | 30 | 0.340 |
Why?
|
| Interleukin-17 | 2 | 2024 | 257 | 0.340 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 4 | 2015 | 1547 | 0.340 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2012 | 620 | 0.340 |
Why?
|
| Genes, Retinoblastoma | 1 | 2009 | 93 | 0.340 |
Why?
|
| Protein Stability | 4 | 2020 | 376 | 0.330 |
Why?
|
| Loss of Heterozygosity | 5 | 2017 | 626 | 0.330 |
Why?
|
| Serine | 5 | 2004 | 394 | 0.320 |
Why?
|
| Exonucleases | 2 | 2006 | 52 | 0.320 |
Why?
|
| Molecular Sequence Data | 24 | 2007 | 6781 | 0.320 |
Why?
|
| Disease Progression | 8 | 2022 | 6909 | 0.320 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 12 | 2012 | 3651 | 0.320 |
Why?
|
| Myocardium | 1 | 2014 | 1251 | 0.310 |
Why?
|
| Male | 53 | 2024 | 128957 | 0.310 |
Why?
|
| Cell Differentiation | 12 | 2021 | 4195 | 0.310 |
Why?
|
| Sarcoma | 3 | 2017 | 1842 | 0.310 |
Why?
|
| Introns | 8 | 2011 | 461 | 0.310 |
Why?
|
| Polymorphism, Single Nucleotide | 7 | 2018 | 4639 | 0.310 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2015 | 802 | 0.310 |
Why?
|
| Genes, p16 | 1 | 2008 | 132 | 0.300 |
Why?
|
| Hematopoiesis | 4 | 2016 | 608 | 0.300 |
Why?
|
| Limb Deformities, Congenital | 1 | 2008 | 116 | 0.300 |
Why?
|
| Genetic Engineering | 1 | 2009 | 298 | 0.300 |
Why?
|
| Tumor Suppressor Protein p14ARF | 4 | 2006 | 101 | 0.290 |
Why?
|
| Haploidy | 1 | 2007 | 43 | 0.290 |
Why?
|
| Central Nervous System | 2 | 2009 | 457 | 0.290 |
Why?
|
| DNA Primers | 9 | 2013 | 1513 | 0.290 |
Why?
|
| Rhabdomyosarcoma | 1 | 2010 | 343 | 0.290 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 5 | 2011 | 507 | 0.280 |
Why?
|
| Cellular Senescence | 4 | 2017 | 390 | 0.280 |
Why?
|
| Repressor Proteins | 2 | 2012 | 1730 | 0.280 |
Why?
|
| Receptors, Cytokine | 2 | 2018 | 183 | 0.270 |
Why?
|
| Collagen | 9 | 1992 | 739 | 0.260 |
Why?
|
| Sex Factors | 6 | 2019 | 2206 | 0.260 |
Why?
|
| Liver | 4 | 2014 | 3123 | 0.260 |
Why?
|
| Skin Neoplasms | 5 | 2017 | 4889 | 0.260 |
Why?
|
| Alternative Splicing | 2 | 2006 | 613 | 0.260 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2007 | 226 | 0.260 |
Why?
|
| ras Proteins | 5 | 2019 | 802 | 0.250 |
Why?
|
| Mutant Proteins | 3 | 2011 | 235 | 0.250 |
Why?
|
| Mitochondria | 1 | 2012 | 1313 | 0.250 |
Why?
|
| Kidney | 1 | 2014 | 2265 | 0.250 |
Why?
|
| Genes, Tumor Suppressor | 7 | 2011 | 1132 | 0.250 |
Why?
|
| Autophagy-Related Protein-1 Homolog | 1 | 2024 | 12 | 0.240 |
Why?
|
| Protein Isoforms | 3 | 2013 | 860 | 0.240 |
Why?
|
| V-Set Domain-Containing T-Cell Activation Inhibitor 1 | 1 | 2024 | 33 | 0.240 |
Why?
|
| Receptors, Interleukin-17 | 1 | 2024 | 26 | 0.240 |
Why?
|
| Intestine, Small | 2 | 2020 | 527 | 0.240 |
Why?
|
| Cell Division | 8 | 2017 | 2711 | 0.240 |
Why?
|
| Retinoblastoma Protein | 2 | 2005 | 342 | 0.230 |
Why?
|
| Cloning, Molecular | 10 | 1998 | 1458 | 0.230 |
Why?
|
| Down-Regulation | 7 | 2021 | 2106 | 0.230 |
Why?
|
| Stem Cells | 3 | 2007 | 1236 | 0.230 |
Why?
|
| Tumor Microenvironment | 3 | 2024 | 3022 | 0.230 |
Why?
|
| Homozygote | 3 | 2018 | 771 | 0.230 |
Why?
|
| Phosphorylation | 12 | 2019 | 4984 | 0.230 |
Why?
|
| Genotype | 8 | 2016 | 4265 | 0.230 |
Why?
|
| HeLa Cells | 9 | 2013 | 1718 | 0.230 |
Why?
|
| Recombinant Fusion Proteins | 9 | 2006 | 1668 | 0.230 |
Why?
|
| Mice, Inbred BALB C | 6 | 2017 | 2469 | 0.220 |
Why?
|
| Longevity | 2 | 2016 | 155 | 0.220 |
Why?
|
| Phosphoproteins | 4 | 2013 | 1230 | 0.220 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2023 | 24 | 0.220 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2010 | 917 | 0.220 |
Why?
|
| TATA-Binding Protein Associated Factors | 2 | 2002 | 27 | 0.220 |
Why?
|
| Mammary Glands, Animal | 3 | 2021 | 635 | 0.220 |
Why?
|
| Transfection | 12 | 2015 | 3165 | 0.220 |
Why?
|
| Feedback, Physiological | 2 | 2014 | 194 | 0.220 |
Why?
|
| Neoplasm Invasiveness | 4 | 2019 | 4071 | 0.210 |
Why?
|
| Mice, Inbred Strains | 4 | 2018 | 570 | 0.210 |
Why?
|
| Blotting, Western | 7 | 2012 | 3646 | 0.210 |
Why?
|
| Doxorubicin | 5 | 2014 | 3131 | 0.210 |
Why?
|
| Lung Neoplasms | 9 | 2024 | 12012 | 0.210 |
Why?
|
| Models, Biological | 9 | 2019 | 3223 | 0.210 |
Why?
|
| Point Mutation | 4 | 2014 | 793 | 0.210 |
Why?
|
| Carcinoma, Adenoid Cystic | 2 | 2017 | 446 | 0.200 |
Why?
|
| Salivary Gland Neoplasms | 2 | 2017 | 499 | 0.200 |
Why?
|
| Skin | 3 | 2017 | 1284 | 0.200 |
Why?
|
| Protein Structure, Tertiary | 4 | 2007 | 1501 | 0.200 |
Why?
|
| Models, Animal | 3 | 2014 | 675 | 0.200 |
Why?
|
| Polyamines | 1 | 2021 | 80 | 0.190 |
Why?
|
| Blotting, Northern | 8 | 2003 | 735 | 0.190 |
Why?
|
| Amino Acid Sequence | 15 | 2007 | 4635 | 0.190 |
Why?
|
| Biomarkers, Tumor | 7 | 2021 | 10750 | 0.190 |
Why?
|
| Hepatocytes | 2 | 2022 | 350 | 0.190 |
Why?
|
| Transgenes | 2 | 2017 | 589 | 0.190 |
Why?
|
| Wnt Signaling Pathway | 2 | 2021 | 445 | 0.190 |
Why?
|
| Gamma Rays | 3 | 2004 | 241 | 0.190 |
Why?
|
| Islets of Langerhans | 1 | 2022 | 241 | 0.190 |
Why?
|
| Pseudogenes | 1 | 2001 | 92 | 0.190 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2013 | 503 | 0.190 |
Why?
|
| Primary Cell Culture | 2 | 2021 | 203 | 0.190 |
Why?
|
| S Phase | 2 | 1999 | 290 | 0.190 |
Why?
|
| Polymerization | 1 | 2020 | 17 | 0.190 |
Why?
|
| Models, Theoretical | 2 | 2008 | 809 | 0.190 |
Why?
|
| Pancreas | 2 | 2024 | 746 | 0.180 |
Why?
|
| Duodenal Neoplasms | 1 | 2021 | 139 | 0.180 |
Why?
|
| Immunohistochemistry | 6 | 2016 | 7822 | 0.180 |
Why?
|
| Penetrance | 1 | 2021 | 134 | 0.180 |
Why?
|
| DNA Repair | 3 | 2010 | 1912 | 0.180 |
Why?
|
| Multiple Endocrine Neoplasia Type 1 | 1 | 2021 | 143 | 0.180 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2020 | 512 | 0.180 |
Why?
|
| Osteoblasts | 3 | 2021 | 394 | 0.180 |
Why?
|
| beta Catenin | 2 | 2021 | 691 | 0.180 |
Why?
|
| MAP Kinase Signaling System | 2 | 2019 | 889 | 0.180 |
Why?
|
| Carcinosarcoma | 1 | 2021 | 149 | 0.180 |
Why?
|
| Ribonucleotide Reductases | 1 | 2000 | 48 | 0.180 |
Why?
|
| Antineoplastic Agents | 6 | 2024 | 14653 | 0.170 |
Why?
|
| Cell Plasticity | 1 | 2020 | 67 | 0.170 |
Why?
|
| DNA Mutational Analysis | 9 | 2017 | 2365 | 0.170 |
Why?
|
| Sequence Deletion | 5 | 2016 | 915 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2020 | 177 | 0.170 |
Why?
|
| Heart | 1 | 2006 | 1214 | 0.170 |
Why?
|
| Transforming Growth Factor beta | 3 | 2013 | 1133 | 0.160 |
Why?
|
| Mutagenesis, Site-Directed | 5 | 2004 | 641 | 0.160 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2019 | 82 | 0.160 |
Why?
|
| Neoplastic Stem Cells | 3 | 2018 | 1469 | 0.160 |
Why?
|
| Genes, myc | 2 | 2011 | 375 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2022 | 2085 | 0.160 |
Why?
|
| 3T3 Cells | 7 | 2011 | 387 | 0.160 |
Why?
|
| Protein Domains | 1 | 2020 | 324 | 0.160 |
Why?
|
| Histones | 5 | 2018 | 1514 | 0.160 |
Why?
|
| Mutation Rate | 1 | 2019 | 220 | 0.160 |
Why?
|
| Rats | 8 | 2018 | 6638 | 0.160 |
Why?
|
| Peptide Hydrolases | 2 | 2011 | 264 | 0.160 |
Why?
|
| Germ Cells | 1 | 2021 | 351 | 0.160 |
Why?
|
| Gene Knock-In Techniques | 5 | 2021 | 184 | 0.160 |
Why?
|
| Chromosomes, Human, X | 1 | 2019 | 201 | 0.160 |
Why?
|
| Hyperpigmentation | 2 | 2016 | 35 | 0.160 |
Why?
|
| Fungal Proteins | 3 | 1998 | 272 | 0.160 |
Why?
|
| Spondylarthropathies | 1 | 2018 | 5 | 0.160 |
Why?
|
| Recombinational DNA Repair | 1 | 2018 | 78 | 0.160 |
Why?
|
| Protein Transport | 1 | 2020 | 739 | 0.150 |
Why?
|
| Cell Survival | 8 | 2015 | 3074 | 0.150 |
Why?
|
| Adenocarcinoma in Situ | 1 | 2018 | 31 | 0.150 |
Why?
|
| Keratinocytes | 2 | 2017 | 247 | 0.150 |
Why?
|
| DNA End-Joining Repair | 1 | 2018 | 92 | 0.150 |
Why?
|
| Phosphoserine | 2 | 2001 | 109 | 0.150 |
Why?
|
| Chromosome Mapping | 5 | 2006 | 1650 | 0.150 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2018 | 1613 | 0.150 |
Why?
|
| Biomarkers | 3 | 2020 | 5112 | 0.150 |
Why?
|
| Cell Line | 9 | 2013 | 5432 | 0.150 |
Why?
|
| fas Receptor | 2 | 2002 | 197 | 0.150 |
Why?
|
| Thymus Gland | 2 | 2004 | 312 | 0.150 |
Why?
|
| Leupeptins | 2 | 2014 | 73 | 0.150 |
Why?
|
| Melanocytes | 2 | 2016 | 241 | 0.140 |
Why?
|
| Laryngeal Neoplasms | 1 | 2001 | 533 | 0.140 |
Why?
|
| RNA Splicing | 2 | 2017 | 362 | 0.140 |
Why?
|
| Obesity | 2 | 2023 | 2958 | 0.140 |
Why?
|
| Receptors, Endothelin | 2 | 2014 | 25 | 0.140 |
Why?
|
| Mice, Nude | 5 | 2021 | 4359 | 0.140 |
Why?
|
| Receptors, Angiotensin | 2 | 2014 | 46 | 0.140 |
Why?
|
| Receptors, Interleukin | 4 | 2018 | 99 | 0.140 |
Why?
|
| Gene Regulatory Networks | 1 | 2021 | 681 | 0.140 |
Why?
|
| NF-kappa B | 2 | 2013 | 1568 | 0.140 |
Why?
|
| History, 21st Century | 1 | 2018 | 422 | 0.140 |
Why?
|
| RNA, Neoplasm | 2 | 2014 | 810 | 0.140 |
Why?
|
| Transformation, Genetic | 3 | 2001 | 70 | 0.140 |
Why?
|
| Epithelial Cells | 4 | 2024 | 1891 | 0.140 |
Why?
|
| Bromodeoxyuridine | 3 | 2009 | 138 | 0.140 |
Why?
|
| Mitosis | 4 | 2007 | 692 | 0.140 |
Why?
|
| Genetic Vectors | 3 | 2003 | 1885 | 0.140 |
Why?
|
| Interleukin-27 | 1 | 2016 | 7 | 0.140 |
Why?
|
| Oxidative Phosphorylation | 1 | 2018 | 267 | 0.130 |
Why?
|
| Oncogene Proteins | 2 | 2005 | 370 | 0.130 |
Why?
|
| Receptor, Endothelin A | 1 | 2016 | 18 | 0.130 |
Why?
|
| History, 20th Century | 1 | 2018 | 550 | 0.130 |
Why?
|
| Carcinogens | 1 | 2017 | 398 | 0.130 |
Why?
|
| Cell Growth Processes | 2 | 2014 | 340 | 0.130 |
Why?
|
| Contact Inhibition | 1 | 1995 | 10 | 0.130 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2022 | 1575 | 0.130 |
Why?
|
| Mouth Neoplasms | 1 | 2001 | 734 | 0.130 |
Why?
|
| Clonal Evolution | 1 | 2017 | 251 | 0.130 |
Why?
|
| NFI Transcription Factors | 1 | 2015 | 78 | 0.130 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2020 | 2352 | 0.130 |
Why?
|
| Animals, Genetically Modified | 2 | 2015 | 417 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 1 | 3 | 2013 | 355 | 0.120 |
Why?
|
| Polycomb Repressive Complex 2 | 1 | 2015 | 160 | 0.120 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2007 | 1093 | 0.120 |
Why?
|
| Mitochondrial Turnover | 1 | 2014 | 6 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 8 | 2014 | 3512 | 0.120 |
Why?
|
| RNA, Small Interfering | 5 | 2022 | 2218 | 0.120 |
Why?
|
| Drug Synergism | 1 | 2018 | 1364 | 0.120 |
Why?
|
| Immunomodulation | 1 | 2016 | 255 | 0.120 |
Why?
|
| Cycloheximide | 1 | 2014 | 111 | 0.120 |
Why?
|
| Heart Defects, Congenital | 1 | 2006 | 1781 | 0.120 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 2 | 2006 | 437 | 0.120 |
Why?
|
| Tumor Cells, Cultured | 15 | 2003 | 5804 | 0.110 |
Why?
|
| Dactinomycin | 1 | 2014 | 163 | 0.110 |
Why?
|
| Response Elements | 1 | 2014 | 200 | 0.110 |
Why?
|
| Ubiquitin-Specific Proteases | 1 | 2014 | 71 | 0.110 |
Why?
|
| NFATC Transcription Factors | 1 | 2014 | 98 | 0.110 |
Why?
|
| Pedigree | 7 | 2011 | 2036 | 0.110 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2014 | 171 | 0.110 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2014 | 191 | 0.110 |
Why?
|
| Ploidies | 2 | 2004 | 257 | 0.110 |
Why?
|
| Injections | 1 | 2014 | 286 | 0.110 |
Why?
|
| B-Lymphocytes | 2 | 2010 | 1429 | 0.110 |
Why?
|
| Cerebellum | 2 | 2007 | 476 | 0.110 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2017 | 2496 | 0.110 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2015 | 227 | 0.110 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2015 | 294 | 0.110 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2018 | 5421 | 0.110 |
Why?
|
| Leukemia, Promyelocytic, Acute | 2 | 2013 | 439 | 0.110 |
Why?
|
| Chromosome Inversion | 1 | 2014 | 197 | 0.110 |
Why?
|
| Binding Sites | 6 | 2012 | 2298 | 0.110 |
Why?
|
| G1 Phase Cell Cycle Checkpoints | 1 | 2013 | 46 | 0.110 |
Why?
|
| Psoriasis | 1 | 2014 | 137 | 0.110 |
Why?
|
| Transcription Factor RelA | 1 | 2013 | 185 | 0.110 |
Why?
|
| Translocation, Genetic | 2 | 2015 | 1288 | 0.110 |
Why?
|
| Animals, Newborn | 3 | 2007 | 1396 | 0.110 |
Why?
|
| Gene Expression Profiling | 5 | 2017 | 5186 | 0.110 |
Why?
|
| Chickens | 4 | 2010 | 791 | 0.110 |
Why?
|
| Th1 Cells | 1 | 2014 | 260 | 0.110 |
Why?
|
| Enhancer Elements, Genetic | 2 | 1995 | 504 | 0.100 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2018 | 848 | 0.100 |
Why?
|
| Head and Neck Neoplasms | 2 | 2007 | 4137 | 0.100 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2014 | 272 | 0.100 |
Why?
|
| Saccharomyces cerevisiae Proteins | 2 | 1993 | 473 | 0.100 |
Why?
|
| Fatty Liver | 1 | 2014 | 257 | 0.100 |
Why?
|
| beta-Galactosidase | 2 | 2009 | 278 | 0.100 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2016 | 6270 | 0.100 |
Why?
|
| Prostatic Neoplasms | 4 | 2022 | 5996 | 0.100 |
Why?
|
| Genomic Instability | 1 | 2015 | 522 | 0.100 |
Why?
|
| Proteolysis | 1 | 2014 | 380 | 0.100 |
Why?
|
| Shc Signaling Adaptor Proteins | 1 | 2011 | 28 | 0.100 |
Why?
|
| Survival Analysis | 4 | 2010 | 9325 | 0.100 |
Why?
|
| Precipitin Tests | 4 | 2003 | 360 | 0.100 |
Why?
|
| Genomics | 3 | 2017 | 2830 | 0.100 |
Why?
|
| Glioblastoma | 1 | 2022 | 1781 | 0.100 |
Why?
|
| Research Report | 1 | 2012 | 144 | 0.100 |
Why?
|
| Smad Proteins | 1 | 2011 | 82 | 0.100 |
Why?
|
| Blotting, Southern | 2 | 2011 | 455 | 0.100 |
Why?
|
| Glioma | 1 | 2022 | 1988 | 0.100 |
Why?
|
| Transcription Factor TFIID | 2 | 2002 | 26 | 0.100 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2012 | 196 | 0.090 |
Why?
|
| Myocytes, Cardiac | 2 | 2007 | 710 | 0.090 |
Why?
|
| Peptidylprolyl Isomerase | 1 | 2011 | 72 | 0.090 |
Why?
|
| Hematologic Diseases | 1 | 2012 | 255 | 0.090 |
Why?
|
| DNA-Activated Protein Kinase | 2 | 2022 | 76 | 0.090 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2014 | 1004 | 0.090 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2013 | 569 | 0.090 |
Why?
|
| Gene Expression Regulation, Enzymologic | 3 | 2007 | 703 | 0.090 |
Why?
|
| Flow Cytometry | 3 | 2018 | 3078 | 0.090 |
Why?
|
| Exons | 5 | 2003 | 1388 | 0.090 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1991 | 265 | 0.090 |
Why?
|
| Cerebellar Ataxia | 1 | 2011 | 73 | 0.090 |
Why?
|
| Casein Kinase II | 3 | 2001 | 60 | 0.090 |
Why?
|
| Lipids | 1 | 2014 | 662 | 0.090 |
Why?
|
| Stress, Physiological | 1 | 2014 | 494 | 0.090 |
Why?
|
| Zinc Fingers | 2 | 2005 | 224 | 0.090 |
Why?
|
| Immunoprecipitation | 2 | 2013 | 593 | 0.090 |
Why?
|
| Cell Movement | 4 | 2016 | 2504 | 0.090 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 3 | 1999 | 192 | 0.090 |
Why?
|
| Oligonucleotides | 2 | 2010 | 245 | 0.090 |
Why?
|
| Retina | 1 | 2014 | 543 | 0.090 |
Why?
|
| ErbB Receptors | 3 | 2022 | 2383 | 0.090 |
Why?
|
| Protein Multimerization | 1 | 2011 | 233 | 0.090 |
Why?
|
| 5' Untranslated Regions | 1 | 2010 | 99 | 0.090 |
Why?
|
| bcl-2-Associated X Protein | 2 | 2003 | 380 | 0.090 |
Why?
|
| Survival Rate | 4 | 2007 | 12533 | 0.090 |
Why?
|
| STAT3 Transcription Factor | 1 | 2017 | 1146 | 0.090 |
Why?
|
| Genes, Dominant | 3 | 2011 | 360 | 0.090 |
Why?
|
| Chemokine CXCL12 | 1 | 2010 | 136 | 0.090 |
Why?
|
| Proto-Oncogenes | 1 | 1990 | 208 | 0.090 |
Why?
|
| Osteogenesis | 3 | 2021 | 271 | 0.090 |
Why?
|
| Feedback | 2 | 2010 | 227 | 0.090 |
Why?
|
| Adipocytes | 1 | 2012 | 308 | 0.090 |
Why?
|
| E2F3 Transcription Factor | 1 | 2009 | 23 | 0.090 |
Why?
|
| Nevus | 1 | 2010 | 117 | 0.090 |
Why?
|
| Adenocarcinoma, Follicular | 1 | 2011 | 131 | 0.090 |
Why?
|
| Retinoblastoma | 1 | 2011 | 189 | 0.090 |
Why?
|
| Chromosome Aberrations | 1 | 2017 | 2034 | 0.090 |
Why?
|
| DNA Replication | 2 | 2004 | 772 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2011 | 490 | 0.080 |
Why?
|
| 3' Untranslated Regions | 1 | 2010 | 339 | 0.080 |
Why?
|
| Cisplatin | 3 | 2016 | 2497 | 0.080 |
Why?
|
| CD3 Complex | 1 | 2010 | 321 | 0.080 |
Why?
|
| Macrophages | 1 | 2016 | 1377 | 0.080 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 5 | 2024 | 5566 | 0.080 |
Why?
|
| Genome, Human | 2 | 2015 | 1885 | 0.080 |
Why?
|
| Tumor Burden | 2 | 2012 | 2035 | 0.080 |
Why?
|
| Cell Nucleus | 5 | 2004 | 1740 | 0.080 |
Why?
|
| Bone Marrow | 2 | 2007 | 2435 | 0.080 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2022 | 1014 | 0.080 |
Why?
|
| Exoribonucleases | 2 | 2006 | 43 | 0.080 |
Why?
|
| Proto-Oncogene Protein c-fli-1 | 1 | 2008 | 50 | 0.080 |
Why?
|
| Time Factors | 9 | 2017 | 13130 | 0.080 |
Why?
|
| Multiprotein Complexes | 1 | 2011 | 389 | 0.080 |
Why?
|
| Insulin Resistance | 1 | 2014 | 747 | 0.080 |
Why?
|
| RNA-Binding Protein EWS | 1 | 2008 | 106 | 0.080 |
Why?
|
| Enzyme Activation | 4 | 2007 | 1832 | 0.080 |
Why?
|
| Mice, 129 Strain | 2 | 2021 | 163 | 0.080 |
Why?
|
| Breast | 3 | 2021 | 1380 | 0.080 |
Why?
|
| Restriction Mapping | 4 | 1998 | 336 | 0.080 |
Why?
|
| Hippocampus | 1 | 2014 | 976 | 0.080 |
Why?
|
| 14-3-3 Proteins | 2 | 2006 | 143 | 0.080 |
Why?
|
| Pregnancy | 4 | 2023 | 8100 | 0.080 |
Why?
|
| Methylation | 3 | 2015 | 626 | 0.070 |
Why?
|
| Immunoblotting | 4 | 2013 | 909 | 0.070 |
Why?
|
| Immune Tolerance | 1 | 2010 | 431 | 0.070 |
Why?
|
| Models, Genetic | 2 | 2014 | 1168 | 0.070 |
Why?
|
| G1 Phase | 2 | 2000 | 306 | 0.070 |
Why?
|
| Actins | 1 | 2010 | 616 | 0.070 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2007 | 107 | 0.070 |
Why?
|
| Growth | 1 | 2007 | 125 | 0.070 |
Why?
|
| Tripartite Motif Proteins | 3 | 2014 | 51 | 0.070 |
Why?
|
| Disease-Free Survival | 2 | 2017 | 10259 | 0.070 |
Why?
|
| Polymorphism, Genetic | 3 | 2014 | 1559 | 0.070 |
Why?
|
| Protein Biosynthesis | 2 | 2010 | 1035 | 0.070 |
Why?
|
| Papilloma | 4 | 2007 | 88 | 0.070 |
Why?
|
| Erythropoiesis | 1 | 2006 | 79 | 0.070 |
Why?
|
| Ubiquitin-Specific Peptidase 7 | 1 | 2006 | 40 | 0.070 |
Why?
|
| X-Ray Microtomography | 2 | 2018 | 138 | 0.070 |
Why?
|
| Wnt Proteins | 1 | 2008 | 392 | 0.070 |
Why?
|
| Caffeine | 1 | 2006 | 96 | 0.070 |
Why?
|
| Tripartite Motif-Containing Protein 28 | 1 | 2006 | 38 | 0.070 |
Why?
|
| DNA Modification Methylases | 1 | 2006 | 176 | 0.070 |
Why?
|
| Centromere | 2 | 2023 | 139 | 0.060 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2010 | 716 | 0.060 |
Why?
|
| Medical Informatics | 1 | 2008 | 195 | 0.060 |
Why?
|
| Adipogenesis | 2 | 2021 | 104 | 0.060 |
Why?
|
| Erythrocytes | 1 | 2006 | 340 | 0.060 |
Why?
|
| Protein Kinases | 1 | 2009 | 919 | 0.060 |
Why?
|
| Spermatogenesis | 1 | 2007 | 334 | 0.060 |
Why?
|
| Genome-Wide Association Study | 1 | 2014 | 2333 | 0.060 |
Why?
|
| Hepatomegaly | 1 | 2005 | 72 | 0.060 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2017 | 2634 | 0.060 |
Why?
|
| DNA Repair Enzymes | 1 | 2006 | 236 | 0.060 |
Why?
|
| RNA Interference | 3 | 2015 | 1397 | 0.060 |
Why?
|
| Biomedical Research | 1 | 2012 | 802 | 0.060 |
Why?
|
| Temperature | 2 | 2000 | 540 | 0.060 |
Why?
|
| Histone Acetyltransferases | 1 | 2007 | 442 | 0.060 |
Why?
|
| Pyridines | 2 | 2024 | 1312 | 0.060 |
Why?
|
| Mosaicism | 1 | 2007 | 293 | 0.060 |
Why?
|
| Endopeptidases | 1 | 2006 | 233 | 0.060 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 2 | 1995 | 139 | 0.060 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2006 | 224 | 0.060 |
Why?
|
| Gene Silencing | 1 | 2007 | 832 | 0.060 |
Why?
|
| Simian virus 40 | 4 | 1991 | 248 | 0.060 |
Why?
|
| Ankyrins | 1 | 2005 | 110 | 0.060 |
Why?
|
| Drosophila | 2 | 2007 | 911 | 0.060 |
Why?
|
| Lod Score | 1 | 2004 | 169 | 0.060 |
Why?
|
| Teratoma | 2 | 1999 | 253 | 0.060 |
Why?
|
| HCT116 Cells | 2 | 2015 | 354 | 0.060 |
Why?
|
| Mathematics | 1 | 2004 | 141 | 0.060 |
Why?
|
| High Mobility Group Proteins | 2 | 2001 | 65 | 0.060 |
Why?
|
| Fetal Death | 1 | 2004 | 134 | 0.060 |
Why?
|
| Genetic Markers | 2 | 2004 | 1076 | 0.060 |
Why?
|
| E2F1 Transcription Factor | 2 | 2009 | 201 | 0.060 |
Why?
|
| Adenovirus E1A Proteins | 1 | 2004 | 165 | 0.060 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2010 | 1136 | 0.060 |
Why?
|
| Haplotypes | 2 | 2014 | 909 | 0.060 |
Why?
|
| Proteins | 3 | 2000 | 2058 | 0.060 |
Why?
|
| cdc25 Phosphatases | 1 | 2004 | 101 | 0.060 |
Why?
|
| Nucleotides | 2 | 2004 | 175 | 0.060 |
Why?
|
| Multigene Family | 1 | 2005 | 465 | 0.060 |
Why?
|
| Genes, Recessive | 1 | 2004 | 202 | 0.060 |
Why?
|
| Telomere | 1 | 2007 | 546 | 0.060 |
Why?
|
| Amino Acid Substitution | 3 | 2018 | 661 | 0.060 |
Why?
|
| Ovarian Neoplasms | 2 | 2016 | 4795 | 0.060 |
Why?
|
| Middle Aged | 9 | 2021 | 90395 | 0.060 |
Why?
|
| Choroid Plexus | 3 | 1988 | 37 | 0.050 |
Why?
|
| Neural Tube Defects | 1 | 2007 | 369 | 0.050 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 1994 | 294 | 0.050 |
Why?
|
| Ligases | 1 | 2003 | 85 | 0.050 |
Why?
|
| Lactation | 2 | 2002 | 244 | 0.050 |
Why?
|
| Teratocarcinoma | 2 | 1999 | 24 | 0.050 |
Why?
|
| MCF-7 Cells | 2 | 2015 | 554 | 0.050 |
Why?
|
| alpha-Thalassemia | 1 | 2022 | 11 | 0.050 |
Why?
|
| Whole-Body Irradiation | 2 | 2009 | 324 | 0.050 |
Why?
|
| Ubiquitins | 1 | 2003 | 100 | 0.050 |
Why?
|
| Methoxsalen | 1 | 2002 | 7 | 0.050 |
Why?
|
| Embryonic and Fetal Development | 2 | 1998 | 229 | 0.050 |
Why?
|
| Cerebral Ventricle Neoplasms | 3 | 1988 | 78 | 0.050 |
Why?
|
| Neuroblastoma | 2 | 2005 | 703 | 0.050 |
Why?
|
| Pleural Neoplasms | 1 | 2007 | 487 | 0.050 |
Why?
|
| Cytoplasm | 2 | 2002 | 718 | 0.050 |
Why?
|
| Sequence Alignment | 2 | 2001 | 883 | 0.050 |
Why?
|
| Adult | 13 | 2021 | 81857 | 0.050 |
Why?
|
| Aged | 7 | 2021 | 73471 | 0.050 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 2001 | 422 | 0.050 |
Why?
|
| Smad3 Protein | 2 | 2013 | 125 | 0.050 |
Why?
|
| Plasmids | 5 | 2002 | 953 | 0.050 |
Why?
|
| HEK293 Cells | 2 | 2018 | 1470 | 0.050 |
Why?
|
| Giant Cells | 1 | 2002 | 73 | 0.050 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2006 | 504 | 0.050 |
Why?
|
| Mesothelioma | 1 | 2007 | 560 | 0.050 |
Why?
|
| Cohort Studies | 4 | 2017 | 9491 | 0.050 |
Why?
|
| Muridae | 1 | 2001 | 23 | 0.050 |
Why?
|
| Epidermis | 1 | 2002 | 200 | 0.050 |
Why?
|
| Antibiotics, Antineoplastic | 3 | 2012 | 744 | 0.050 |
Why?
|
| Mental Retardation, X-Linked | 1 | 2022 | 100 | 0.050 |
Why?
|
| Son of Sevenless Proteins | 1 | 2001 | 8 | 0.050 |
Why?
|
| Genetic Linkage | 2 | 2005 | 601 | 0.050 |
Why?
|
| Chondrogenesis | 1 | 2021 | 64 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2022 | 1482 | 0.050 |
Why?
|
| Case-Control Studies | 3 | 2021 | 6236 | 0.050 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2021 | 7246 | 0.050 |
Why?
|
| Transcriptional Elongation Factors | 1 | 2001 | 42 | 0.050 |
Why?
|
| Acetamides | 1 | 2001 | 111 | 0.050 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2001 | 449 | 0.050 |
Why?
|
| Haploinsufficiency | 2 | 2013 | 303 | 0.050 |
Why?
|
| DNA, Neoplasm | 1 | 2006 | 1972 | 0.050 |
Why?
|
| COP9 Signalosome Complex | 2 | 2011 | 80 | 0.050 |
Why?
|
| Brazil | 1 | 2021 | 172 | 0.050 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 2003 | 252 | 0.050 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2005 | 642 | 0.050 |
Why?
|
| Genes, Synthetic | 1 | 2000 | 30 | 0.040 |
Why?
|
| Integrases | 1 | 2002 | 266 | 0.040 |
Why?
|
| Recombination, Genetic | 1 | 2003 | 668 | 0.040 |
Why?
|
| Genomic Library | 2 | 1998 | 58 | 0.040 |
Why?
|
| Piperazines | 2 | 2024 | 2152 | 0.040 |
Why?
|
| Terminal Repeat Sequences | 1 | 1999 | 29 | 0.040 |
Why?
|
| Thyroid Neoplasms | 1 | 2011 | 1884 | 0.040 |
Why?
|
| Spermatocytes | 1 | 1999 | 48 | 0.040 |
Why?
|
| Enzyme Inhibitors | 2 | 2015 | 1966 | 0.040 |
Why?
|
| Risk Factors | 3 | 2014 | 18045 | 0.040 |
Why?
|
| Genes, X-Linked | 1 | 2019 | 67 | 0.040 |
Why?
|
| Growth Disorders | 2 | 2011 | 224 | 0.040 |
Why?
|
| DNA Helicases | 1 | 2022 | 451 | 0.040 |
Why?
|
| Cartilage | 3 | 1991 | 112 | 0.040 |
Why?
|
| Imidazoles | 2 | 2010 | 1056 | 0.040 |
Why?
|
| Gene Library | 1 | 2001 | 355 | 0.040 |
Why?
|
| Codon | 3 | 2010 | 262 | 0.040 |
Why?
|
| Cell Lineage | 2 | 2015 | 706 | 0.040 |
Why?
|
| Transcription Factors, TFII | 1 | 1999 | 23 | 0.040 |
Why?
|
| Tissue Distribution | 2 | 1999 | 946 | 0.040 |
Why?
|
| Retinoblastoma-Binding Protein 1 | 1 | 1999 | 57 | 0.040 |
Why?
|
| Transcription Factor DP1 | 1 | 1999 | 59 | 0.040 |
Why?
|
| Whole Genome Sequencing | 1 | 2021 | 367 | 0.040 |
Why?
|
| Pyridazines | 1 | 2022 | 319 | 0.040 |
Why?
|
| Cyclin A | 1 | 1999 | 50 | 0.040 |
Why?
|
| United States | 4 | 2021 | 16050 | 0.040 |
Why?
|
| Viral Proteins | 1 | 2002 | 493 | 0.040 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 2 | 2010 | 129 | 0.040 |
Why?
|
| E2F Transcription Factors | 1 | 1999 | 138 | 0.040 |
Why?
|
| Protein Interaction Maps | 1 | 2019 | 150 | 0.040 |
Why?
|
| Prognosis | 5 | 2021 | 22537 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 1999 | 156 | 0.040 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 223 | 0.040 |
Why?
|
| Thyroid Gland | 2 | 2011 | 369 | 0.040 |
Why?
|
| Aspergillus nidulans | 1 | 1998 | 29 | 0.040 |
Why?
|
| Neurons | 2 | 2007 | 2461 | 0.040 |
Why?
|
| Octamer Transcription Factors | 1 | 2018 | 18 | 0.040 |
Why?
|
| Testicular Neoplasms | 2 | 1999 | 555 | 0.040 |
Why?
|
| Genes, Fungal | 1 | 1998 | 97 | 0.040 |
Why?
|
| Gene Amplification | 1 | 2001 | 770 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2021 | 428 | 0.040 |
Why?
|
| Autophagy | 1 | 2024 | 921 | 0.040 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2001 | 689 | 0.040 |
Why?
|
| Retinal Dehydrogenase | 1 | 2018 | 88 | 0.040 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 1997 | 26 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 1999 | 274 | 0.040 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2018 | 107 | 0.040 |
Why?
|
| Blastomeres | 1 | 1997 | 24 | 0.040 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2018 | 143 | 0.040 |
Why?
|
| Quinazolines | 1 | 2022 | 953 | 0.040 |
Why?
|
| Antibody Specificity | 1 | 1998 | 340 | 0.040 |
Why?
|
| Colorectal Neoplasms | 1 | 2013 | 3704 | 0.040 |
Why?
|
| Autoantigens | 1 | 1998 | 249 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2002 | 1104 | 0.040 |
Why?
|
| Pancreatitis, Chronic | 1 | 2018 | 127 | 0.040 |
Why?
|
| Sp1 Transcription Factor | 2 | 2010 | 193 | 0.040 |
Why?
|
| Promyelocytic Leukemia Protein | 2 | 2013 | 56 | 0.040 |
Why?
|
| Prostate | 1 | 2022 | 1138 | 0.040 |
Why?
|
| Transforming Growth Factor alpha | 1 | 1997 | 94 | 0.030 |
Why?
|
| Cyclin E | 1 | 1999 | 283 | 0.030 |
Why?
|
| Creatine Kinase | 2 | 1995 | 97 | 0.030 |
Why?
|
| Caenorhabditis elegans | 1 | 2018 | 282 | 0.030 |
Why?
|
| Antisense Elements (Genetics) | 1 | 1996 | 21 | 0.030 |
Why?
|
| Cosmids | 1 | 1996 | 58 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 1999 | 682 | 0.030 |
Why?
|
| Luciferases | 2 | 2010 | 463 | 0.030 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 1998 | 381 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 2 | 2001 | 2575 | 0.030 |
Why?
|
| Indoles | 1 | 2001 | 1034 | 0.030 |
Why?
|
| Chromosome Breakpoints | 1 | 2015 | 103 | 0.030 |
Why?
|
| Gene Order | 1 | 2015 | 109 | 0.030 |
Why?
|
| Aflatoxin B1 | 1 | 1995 | 8 | 0.030 |
Why?
|
| Jejunum | 1 | 1997 | 234 | 0.030 |
Why?
|
| Gene Frequency | 3 | 2004 | 1241 | 0.030 |
Why?
|
| SEER Program | 1 | 2019 | 1047 | 0.030 |
Why?
|
| Antigens, Polyomavirus Transforming | 2 | 1993 | 154 | 0.030 |
Why?
|
| Polycomb Repressive Complex 1 | 1 | 2015 | 87 | 0.030 |
Why?
|
| Follow-Up Studies | 3 | 2021 | 15267 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2015 | 112 | 0.030 |
Why?
|
| Structure-Activity Relationship | 2 | 1994 | 1005 | 0.030 |
Why?
|
| Epidermal Growth Factor | 1 | 1997 | 445 | 0.030 |
Why?
|
| Phylogeny | 1 | 2017 | 869 | 0.030 |
Why?
|
| Congenital Abnormalities | 1 | 1998 | 281 | 0.030 |
Why?
|
| Suppression, Genetic | 2 | 1994 | 71 | 0.030 |
Why?
|
| Acids | 1 | 1994 | 39 | 0.030 |
Why?
|
| RNA | 2 | 2005 | 1072 | 0.030 |
Why?
|
| Glutamic Acid | 1 | 1996 | 335 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2015 | 296 | 0.030 |
Why?
|
| Ganglia, Spinal | 1 | 1996 | 255 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2015 | 330 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 1997 | 668 | 0.030 |
Why?
|
| Cell Count | 1 | 1995 | 524 | 0.030 |
Why?
|
| Muscle, Skeletal | 2 | 2014 | 1313 | 0.030 |
Why?
|
| Listeriosis | 1 | 2014 | 43 | 0.030 |
Why?
|
| Exome | 1 | 2019 | 1252 | 0.030 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2014 | 73 | 0.030 |
Why?
|
| Listeria monocytogenes | 1 | 2014 | 61 | 0.030 |
Why?
|
| Antibodies, Neutralizing | 1 | 2018 | 514 | 0.030 |
Why?
|
| alpha-Fetoproteins | 1 | 1995 | 256 | 0.030 |
Why?
|
| In Situ Hybridization | 1 | 1996 | 1061 | 0.030 |
Why?
|
| Smoking | 1 | 2003 | 2538 | 0.030 |
Why?
|
| Genetic Testing | 2 | 2004 | 1694 | 0.030 |
Why?
|
| Protein Denaturation | 1 | 2013 | 72 | 0.030 |
Why?
|
| Protein Kinase C | 1 | 1995 | 419 | 0.030 |
Why?
|
| Genes, Reporter | 3 | 2003 | 832 | 0.030 |
Why?
|
| Heterografts | 1 | 2016 | 745 | 0.030 |
Why?
|
| Azoxymethane | 1 | 2013 | 43 | 0.030 |
Why?
|
| Protein Conformation | 2 | 1995 | 1278 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1999 | 2317 | 0.030 |
Why?
|
| Proteomics | 1 | 2021 | 1437 | 0.030 |
Why?
|
| Dextran Sulfate | 1 | 2013 | 70 | 0.030 |
Why?
|
| Clone Cells | 2 | 2010 | 589 | 0.030 |
Why?
|
| Melanoma | 1 | 2010 | 5592 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2014 | 227 | 0.030 |
Why?
|
| Snail Family Transcription Factors | 1 | 2013 | 122 | 0.030 |
Why?
|
| Receptors, Retinoic Acid | 1 | 1994 | 374 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2014 | 278 | 0.030 |
Why?
|
| Isoenzymes | 1 | 1995 | 663 | 0.030 |
Why?
|
| Sex Characteristics | 2 | 2008 | 434 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2015 | 1074 | 0.030 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2006 | 2903 | 0.030 |
Why?
|
| Financing, Government | 1 | 2012 | 38 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 3928 | 0.030 |
Why?
|
| Societies, Scientific | 1 | 2012 | 69 | 0.030 |
Why?
|
| Age Factors | 2 | 2015 | 5520 | 0.030 |
Why?
|
| Cell Communication | 1 | 1995 | 518 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2013 | 397 | 0.030 |
Why?
|
| Diet, High-Fat | 1 | 2014 | 254 | 0.030 |
Why?
|
| Base Composition | 1 | 1992 | 93 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2013 | 267 | 0.030 |
Why?
|
| Muscle Cells | 1 | 2012 | 33 | 0.030 |
Why?
|
| Wnt1 Protein | 1 | 2012 | 102 | 0.030 |
Why?
|
| Tumor Escape | 1 | 2014 | 248 | 0.030 |
Why?
|
| Src Homology 2 Domain-Containing, Transforming Protein 1 | 1 | 2011 | 15 | 0.030 |
Why?
|
| Mammary Tumor Virus, Mouse | 1 | 2012 | 148 | 0.030 |
Why?
|
| Guanidine | 1 | 1991 | 14 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2003 | 320 | 0.020 |
Why?
|
| Research Support as Topic | 1 | 2012 | 120 | 0.020 |
Why?
|
| Exostoses, Multiple Hereditary | 1 | 1991 | 26 | 0.020 |
Why?
|
| Adoptive Transfer | 1 | 2014 | 435 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2024 | 3664 | 0.020 |
Why?
|
| Chick Embryo | 3 | 1987 | 219 | 0.020 |
Why?
|
| Growth Plate | 1 | 1991 | 43 | 0.020 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2013 | 273 | 0.020 |
Why?
|
| Melanoma, Experimental | 1 | 2014 | 385 | 0.020 |
Why?
|
| Smad2 Protein | 1 | 2011 | 92 | 0.020 |
Why?
|
| Guanidines | 1 | 1991 | 61 | 0.020 |
Why?
|
| Cesium Radioisotopes | 1 | 2011 | 38 | 0.020 |
Why?
|
| NIMA-Interacting Peptidylprolyl Isomerase | 1 | 2011 | 63 | 0.020 |
Why?
|
| Mutagenicity Tests | 1 | 2011 | 70 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 3853 | 0.020 |
Why?
|
| Cell Line, Transformed | 2 | 2003 | 431 | 0.020 |
Why?
|
| Pigmentation | 1 | 2010 | 52 | 0.020 |
Why?
|
| Plicamycin | 1 | 2010 | 30 | 0.020 |
Why?
|
| Radiography | 1 | 2015 | 1993 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2014 | 498 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2018 | 2287 | 0.020 |
Why?
|
| Oligonucleotide Probes | 1 | 1990 | 158 | 0.020 |
Why?
|
| Genetic Therapy | 1 | 1998 | 1734 | 0.020 |
Why?
|
| Zinostatin | 1 | 2009 | 4 | 0.020 |
Why?
|
| Dromaiidae | 1 | 2009 | 4 | 0.020 |
Why?
|
| Blastocyst | 1 | 2010 | 144 | 0.020 |
Why?
|
| E2F5 Transcription Factor | 1 | 2009 | 8 | 0.020 |
Why?
|
| Luminescent Measurements | 1 | 2010 | 159 | 0.020 |
Why?
|
| E2F2 Transcription Factor | 1 | 2009 | 27 | 0.020 |
Why?
|
| Rad51 Recombinase | 1 | 2010 | 125 | 0.020 |
Why?
|
| Colitis | 1 | 2013 | 344 | 0.020 |
Why?
|
| E2F4 Transcription Factor | 1 | 2009 | 30 | 0.020 |
Why?
|
| Lymphatic Metastasis | 2 | 2011 | 4968 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 1212 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 1995 | 3072 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 473 | 0.020 |
Why?
|
| Colon | 1 | 2013 | 691 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2010 | 466 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2014 | 1728 | 0.020 |
Why?
|
| Arginine | 2 | 2007 | 510 | 0.020 |
Why?
|
| Checkpoint Kinase 1 | 1 | 2009 | 169 | 0.020 |
Why?
|
| Learning | 1 | 2012 | 432 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2010 | 1086 | 0.020 |
Why?
|
| Young Adult | 2 | 2021 | 22108 | 0.020 |
Why?
|
| Genes, Viral | 1 | 1988 | 257 | 0.020 |
Why?
|
| Glycosaminoglycans | 1 | 1987 | 71 | 0.020 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2021 | 3148 | 0.020 |
Why?
|
| Etoposide | 1 | 2009 | 905 | 0.020 |
Why?
|
| Antigens, Viral, Tumor | 1 | 1987 | 76 | 0.020 |
Why?
|
| Incidence | 2 | 2010 | 5861 | 0.020 |
Why?
|
| Embryo Loss | 1 | 2007 | 42 | 0.020 |
Why?
|
| Adolescent | 4 | 2011 | 32663 | 0.020 |
Why?
|
| Centrosome | 1 | 2007 | 107 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 2 | 1986 | 632 | 0.020 |
Why?
|
| Receptors, Serotonin | 1 | 1986 | 59 | 0.020 |
Why?
|
| Molecular Weight | 3 | 2001 | 727 | 0.020 |
Why?
|
| Stromal Cells | 1 | 2010 | 835 | 0.020 |
Why?
|
| Oncogene Proteins, Viral | 1 | 1987 | 148 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2010 | 1851 | 0.020 |
Why?
|
| Body Weight | 1 | 2011 | 1335 | 0.020 |
Why?
|
| Proteoglycans | 1 | 1987 | 278 | 0.020 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2007 | 111 | 0.020 |
Why?
|
| Proportional Hazards Models | 2 | 2006 | 5118 | 0.020 |
Why?
|
| Aneuploidy | 1 | 2007 | 377 | 0.020 |
Why?
|
| Adenoma | 1 | 2011 | 745 | 0.020 |
Why?
|
| Acetylation | 1 | 2007 | 517 | 0.020 |
Why?
|
| N-Myc Proto-Oncogene Protein | 1 | 2005 | 85 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 6210 | 0.020 |
Why?
|
| Brain | 2 | 1996 | 4252 | 0.020 |
Why?
|
| Xenobiotics | 1 | 2005 | 43 | 0.020 |
Why?
|
| Anemia | 1 | 2011 | 730 | 0.020 |
Why?
|
| Epithelium | 2 | 1998 | 805 | 0.020 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2009 | 895 | 0.020 |
Why?
|
| Glycine | 1 | 2007 | 319 | 0.020 |
Why?
|
| DNA Fragmentation | 1 | 2005 | 208 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2009 | 845 | 0.020 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2004 | 181 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2012 | 33863 | 0.020 |
Why?
|
| Checkpoint Kinase 2 | 1 | 2005 | 131 | 0.010 |
Why?
|
| Sampling Studies | 1 | 2004 | 171 | 0.010 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 2004 | 85 | 0.010 |
Why?
|
| Biological Evolution | 1 | 1985 | 292 | 0.010 |
Why?
|
| In Vitro Techniques | 2 | 1999 | 1742 | 0.010 |
Why?
|
| Genes, Suppressor | 1 | 2003 | 24 | 0.010 |
Why?
|
| NIH 3T3 Cells | 1 | 2003 | 259 | 0.010 |
Why?
|
| Transcription Factor Brn-3 | 1 | 2002 | 12 | 0.010 |
Why?
|
| Transcription Factor Brn-3A | 1 | 2002 | 10 | 0.010 |
Why?
|
| Cytokines | 1 | 2012 | 2840 | 0.010 |
Why?
|
| Lung | 1 | 2014 | 3294 | 0.010 |
Why?
|
| Doxycycline | 1 | 2003 | 178 | 0.010 |
Why?
|
| Genetic Carrier Screening | 1 | 2003 | 101 | 0.010 |
Why?
|
| Hydrogen Bonding | 1 | 2002 | 138 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2010 | 4352 | 0.010 |
Why?
|
| Skin Transplantation | 1 | 2003 | 185 | 0.010 |
Why?
|
| Age of Onset | 1 | 2004 | 852 | 0.010 |
Why?
|
| Philadelphia Chromosome | 1 | 2006 | 834 | 0.010 |
Why?
|
| Threonine | 1 | 2002 | 165 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2003 | 371 | 0.010 |
Why?
|
| Transduction, Genetic | 1 | 2003 | 496 | 0.010 |
Why?
|
| Retroviridae | 1 | 2003 | 376 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 2002 | 212 | 0.010 |
Why?
|
| Infant | 2 | 2011 | 13931 | 0.010 |
Why?
|
| Fas Ligand Protein | 1 | 2002 | 154 | 0.010 |
Why?
|
| Risk Assessment | 2 | 2004 | 6883 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 2001 | 161 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2002 | 481 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2003 | 782 | 0.010 |
Why?
|
| Galactose | 1 | 2001 | 79 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2011 | 16999 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2001 | 300 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 2001 | 342 | 0.010 |
Why?
|
| p21-Activated Kinases | 1 | 2001 | 132 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2001 | 582 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2008 | 2156 | 0.010 |
Why?
|
| Lac Operon | 1 | 1999 | 135 | 0.010 |
Why?
|
| SOX9 Transcription Factor | 1 | 2001 | 178 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 2001 | 499 | 0.010 |
Why?
|
| Caspases | 1 | 2002 | 687 | 0.010 |
Why?
|
| Drug Design | 1 | 2001 | 378 | 0.010 |
Why?
|
| Centromere Protein B | 1 | 1998 | 8 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2001 | 955 | 0.010 |
Why?
|
| DNA, Satellite | 1 | 1998 | 44 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2021 | 39780 | 0.010 |
Why?
|
| Cations | 1 | 1998 | 60 | 0.010 |
Why?
|
| Genetic Complementation Test | 1 | 1998 | 148 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2000 | 1143 | 0.010 |
Why?
|
| Bronchial Neoplasms | 1 | 1998 | 83 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 1999 | 347 | 0.010 |
Why?
|
| DNA, Fungal | 1 | 1998 | 148 | 0.010 |
Why?
|
| X-Rays | 1 | 1998 | 153 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2011 | 8602 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 1998 | 190 | 0.010 |
Why?
|
| Lactoglobulins | 1 | 1997 | 2 | 0.010 |
Why?
|
| DNA, Viral | 1 | 1999 | 764 | 0.010 |
Why?
|
| Tretinoin | 1 | 1999 | 621 | 0.010 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2003 | 1351 | 0.010 |
Why?
|
| Mitotic Index | 1 | 1997 | 166 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 1997 | 407 | 0.010 |
Why?
|
| Biological Transport | 1 | 1997 | 645 | 0.010 |
Why?
|
| Liposomes | 1 | 1998 | 710 | 0.010 |
Why?
|
| Bryostatins | 1 | 1995 | 14 | 0.010 |
Why?
|
| Child | 2 | 2011 | 30492 | 0.010 |
Why?
|
| Carbon Tetrachloride Poisoning | 1 | 1995 | 13 | 0.010 |
Why?
|
| Mice, Inbred DBA | 1 | 1995 | 119 | 0.010 |
Why?
|
| Gene Targeting | 1 | 1997 | 321 | 0.010 |
Why?
|
| Macrolides | 1 | 1995 | 65 | 0.010 |
Why?
|
| Testis | 1 | 1999 | 753 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 1997 | 674 | 0.010 |
Why?
|
| Lactones | 1 | 1995 | 93 | 0.010 |
Why?
|
| Cattle | 1 | 1997 | 846 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 1998 | 1566 | 0.010 |
Why?
|
| Retinoic Acid Receptor alpha | 1 | 1994 | 95 | 0.010 |
Why?
|
| Glucose | 1 | 2001 | 1244 | 0.010 |
Why?
|
| Liver Regeneration | 1 | 1995 | 134 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2011 | 7929 | 0.010 |
Why?
|
| Carcinoma | 1 | 2004 | 2623 | 0.010 |
Why?
|
| Hepatitis B | 1 | 1995 | 274 | 0.010 |
Why?
|
| Precancerous Conditions | 1 | 1998 | 1065 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2003 | 3176 | 0.010 |
Why?
|
| Extremities | 1 | 1991 | 309 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 1997 | 1443 | 0.010 |
Why?
|
| Hepatectomy | 1 | 1995 | 1013 | 0.000 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1995 | 5104 | 0.000 |
Why?
|
| Radioligand Assay | 1 | 1986 | 57 | 0.000 |
Why?
|
| DNA Restriction Enzymes | 1 | 1985 | 162 | 0.000 |
Why?
|
| Trypsin | 1 | 1985 | 158 | 0.000 |
Why?
|
| Procollagen | 1 | 1985 | 32 | 0.000 |
Why?
|
| Tumor Virus Infections | 1 | 1986 | 249 | 0.000 |
Why?
|
| Antigens, Viral | 1 | 1986 | 520 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2003 | 31042 | 0.000 |
Why?
|
| Amino Acids | 1 | 1985 | 788 | 0.000 |
Why?
|
| DNA, Recombinant | 1 | 1980 | 161 | 0.000 |
Why?
|
| Peptide Fragments | 1 | 1985 | 1327 | 0.000 |
Why?
|
| Microscopy, Electron | 1 | 1980 | 734 | 0.000 |
Why?
|